ABSTRACT
OBJECTIVE@#To explore the genetic basis of a Chinese pedigree affected with chronic kidney disease (CKD).@*METHODS@#A Chinese pedigree comprised of 10 individuals from four generation who had visited the First Affiliated Hospital of Dali University from August 15, 2018 to July 5, 2021 was selected as the study subject. Clinical data of the proband were collected, and a pedigree survey was conducted. The proband was subjected to whole exome sequencing (WES). Candidate variant was verified by Sanger sequencing and bioinformatic analysis.@*RESULTS@#The proband, a 41-year-old female, has been diagnosed with chronic nephritis for more than 4 years. Routine urinary examination showed proteinuria and blood creatinine of 1 130 μmol/L. Renal biopsy has revealed hyperplastic glomerulonephritis, moderate tubulointerstitial disease and renal arteriosclerosis. Her elder sister, younger brother, younger sister and mother were all diagnosed with CKD stage 5. Except for her elder sister, all of them had deceased, whilst no abnormality was found in the remainders. Genetic testing revealed that the proband and four family members had harbored a c.467G>A missense variant of the PAX2 gene. The variant has been associated with focal segmental glomerulosclerosis and classified as likely pathogenic (PS1+PP3+PP4) based on the guidelines from the American College of Medical Genetics and Genomics (ACMG).@*CONCLUSION@#The c.167G>A variant of the PAX2 gene probably underlay the CKD in this Chinese pedigree.
Subject(s)
Adult , Female , Humans , Male , East Asian People , Genetic Testing , Mutation , PAX2 Transcription Factor/genetics , Pedigree , Renal Insufficiency, Chronic/geneticsABSTRACT
ABSTRACT Introduction: Fabry disease is a chronic, progressive, and multi-system hereditary condition, related to an Xq22 mutation in X chromosome, which results in deficiency of alpha-galactosidase enzyme, hence reduced capacity of globotriaosylceramide degradation. Objectives: to evaluate the prevalence of Fabry disease (FD) mutations, as well as its signs and symptoms, among relatives of chronic kidney disease (CKD) patients diagnosed with FD during a previously conducted study, named "Clinical and epidemiological analysis of Fabry disease in dialysis centers in Brazil". Methods: a cross-sectional study was carried out, and data was collected by interviewing the relatives of patients enrolled in the Brazil Fabry Kidney Project and blood tests for both Gb3 dosage and genetic testing. Results: Among 1214 interviewed relatives, 115 (9.47%) were diagnosed with FD, with a predominance of women (66.10%). The most prevalent comorbidities were rheumatologic conditions and systemic hypertension (1.7% each), followed by heart, neurological, cerebrovascular diseases, and depression in 0.9% of individuals. Intolerance to physical exercise and tiredness were the most observed symptoms (1.7%), followed by periodic fever, intolerance to heat or cold, diffuse pain, burn sensation or numbness in hands and feet, reduced or absent sweating, as well as abdominal pain after meals in 0.9%. Conclusion: We found a prevalence of Fabry disease in 9.47% of relatives of CKD patients with this condition, remarkably with a 66.1% predominance of women, which contrasts with previous reports. The screening of family members of FD patients is important, since it can lead to early diagnosis and treatment, thus allowing better quality of life and improved clinical outcomes for these individuals.
RESUMO Introdução: A doença de Fabry é uma condição hereditária crônica, progressiva e multissistêmica, relacionada a uma mutação Xq22 no cromossomo X, que resulta em deficiência da enzima alfa-galactosidase, diminuindo a capacidade de degradação da globotriaosilceramida. Objetivos: avaliar a prevalência de mutações na doença de Fabry, bem como seus sinais e sintomas, em familiares de pacientes com doença renal crônica (DRC) diagnosticados com DF durante um estudo realizado anteriormente, denominado "Análise clínica e epidemiológica da doença de Fabry em centros de diálise no Brasil". Métodos: foi realizado um estudo transversal e os dados foram coletados através da entrevista com familiares de pacientes inscritos no Projeto Rim Fabry Brasil e exames de sangue para dosagem de Gb3 e testes genéticos. Resultados: Dos 1,214 familiares entrevistados, 115 (9,47%) foram diagnosticados com DF, com predomínio de mulheres (66,10%). As comorbidades mais prevalentes foram condições reumatológicas e hipertensão arterial sistêmica (1,7% cada), seguidas por doenças cardíacas, neurológicas, cerebrovasculares e depressão em 0,9% dos indivíduos. Intolerância ao exercício físico e cansaço foram os sintomas mais observados (1,7%), seguidos de febre periódica, intolerância ao calor ou ao frio, dor difusa, sensação de queimação ou dormência nas mãos e nos pés, sudorese reduzida ou ausente, além de dor abdominal após refeições em 0,9%. Conclusão: Encontramos uma prevalência da doença de Fabry em 9,47% dos familiares de pacientes com DRC com essa condição, notadamente com uma predominância de 66,1% de mulheres, o que contrasta com relatos anteriores. A triagem de familiares de pacientes com DF é importante, pois pode levar ao diagnóstico e tratamento precoces, permitindo melhor qualidade de vida e melhores resultados clínicos para esses indivíduos.
Subject(s)
Humans , Male , Female , Fabry Disease/genetics , Fabry Disease/epidemiology , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/epidemiology , Quality of Life , Family , Cross-Sectional Studies , MutationABSTRACT
ABSTRACT Objective Chronic kidney disease (CKD) risk is inconsistent in the normal-weight, overweight, and obese individuals due to the heterogeneity of metabolic status. This meta-analysis aimed to examine the combined effects of body mass index (BMI) and metabolic status on CKD risk. Materials and methods The MEDLINE, EMBASE, and Web of Knowledge databases were systematically searched up to March 2019 to identify all eligible studies investigating the CKD risk (defined as GFR < 60 mL/min per 1.73 m2 and/or microalbuminuria or proteinuria) associated with the body size phenotypes which are known as metabolically unhealthy normal-weight (MUNW), metabolically healthy overweight (MHOW), metabolically unhealthy overweight, metabolically healthy obese (MHO) and metabolically unhealthy obese (MUHO). The classification of subjects in included studies as metabolically unhealthy was based on the presence of three components of metabolic syndrome. BMI categorization was based on the criteria of included studies. The risk estimates and 95% confidence intervals (CIs) were extracted and pooled using random effects analysis. Results A total of 9 prospective cohort studies with 128773 participants and 4797 incident cases were included in the meta-analysis. Compared with healthy normal-weight individuals as reference, MUNW and MHO subjects showed an increased risk for CKD events with a pooled RR of 1.58 (95% CI = 1.28-1.96) in MUNW and 1.55 (95% CI = 1.34-1.79) in MHO persons. Also, MHOW was at increased risk for CKD (RR = 1.34, 95% CI = 1.20-1.51). MUHO individuals were at the highest risk for the development of CKD (RR = 2.13, 95% CI = 1.66-2.72). Conclusions Individuals with metabolic abnormality, although at normal-weight, have an increased risk for CKD. Healthy overweight and obese individuals had higher risk; refuting the notion that metabolically healthy overweight and obese phenotypes are benign conditions.
Subject(s)
Humans , Phenotype , Body Weight/genetics , Metabolic Syndrome/genetics , Renal Insufficiency, Chronic/genetics , Body Mass Index , Risk , Metabolic Syndrome/metabolism , Observational Studies as Topic , Renal Insufficiency, Chronic/metabolismABSTRACT
Resumen Introducción: La enfermedad renal crónica representa parte del gasto en salud en general; una potencial etiología es la relacionada con variaciones, ausencia o presencia de algunos alelos del human leucocyte antigen (HLA). Método: Se realizó el análisis de 1965 reportes de HLA sin etiología determinada y de 1361 donadores renales. Se llevó a cabo tecnología Luminex con base en fluorimetría de flujo celular para los locus A, B, DRB1 y DQA. Se realizó análisis con tablas de contingencia para determinar razón de momios (RM) e intervalos de confianza (IC). Se efectuó análisis cuantitativo. Resultados: De 101 alelos encontrados, 13 presentaron asociación, siete con riesgo para enfermedad renal crónica, de los cuales el más significativo fue HLA-DR17, con RM = 3.91 (IC 95 % = 2.96-5.17), y el de mayor significación de protección fue HLA-DR9, con RM = 0.043 (IC 95 % = 0.005-0.3224). Conclusiones: Es necesario entender que las enfermedades renales pueden estar ligadas a procesos inmunológicos, en los que se tiene que conocer la asociación de la ausencia o presencia de algún alelo.
Abstract Introduction: Chronic kidney disease accounts for part of overall health expenditure; a potential etiology is related to variations, absence or presence of some human leukocyte antigen (HLA) alleles. Method: An analysis of HLA reports of 1965 kidney recipients with no determined etiology, and 1361 kidney donors was performed. It was carried out with Luminex based in cell flow fluorometry for the A, B, DRB1 and DQA loci. An analysis was performed with contingency tables in order to determine the odds ratio (OR) and confidence intervals (CI). Quantitative analysis was also carried out. Results: Of the 101 alleles found, 13 showed association, 7 with risk for chronic kidney disease, with the most significant being HLA-DR17 with an OR of 3.91 (95 % CI = 2.96-5.17) and the one with the highest significance for protection being HLA-DR9, with an OR of 0.043 (95 % CI = 0.005-0.3224). Conclusions: It is necessary to understand that kidney diseases can be associated with yet unknown immune processes, where the association of the absence or presence of any allele should be known.
Subject(s)
Humans , Tissue Donors , Renal Insufficiency, Chronic/genetics , Transplant Recipients , HLA Antigens/genetics , Retrospective Studies , Risk Factors , Cohort Studies , Kidney Transplantation/methods , Alleles , Renal Insufficiency, Chronic/surgery , Protective Factors , FluorometryABSTRACT
Not much is known about the roles of long non-coding RNAs (lncRNAs) for chronic kidney disease (CKD). In this study, we included CKD patient cohorts and normal controls as a discovery cohort to identify putative lncRNA biomarkers associated with CKD. We first compared the lncRNA expression profiles of CKD patients with normal controls, and identified differentially expressed lncRNAs and mRNAs. Co-expression network based on the enriched differentially expressed mRNAs and lncRNAs was constructed using WGCNA to identify important modules related to CKD. A lncRNA-miRNA-mRNA pathway network based on the hub lncRNAs and mRNAs, related miRNAs, and overlapping pathways was further constructed to reveal putative biomarkers. A total of 821 significantly differentially expressed mRNAs and lncRNAs were screened between CKD and control samples, which were enriched in nine modules using weighted correlation network analysis (WGCNA), especially brown and yellow modules. Co-expression network based on the enriched differentially expressed mRNAs and lncRNAs in brown and yellow modules uncovered 7 hub lncRNAs and 53 hub mRNAs. A lncRNA-miRNA-mRNA pathway network further revealed that lncRNAs of HCP5 and NOP14-AS1 and genes of CCND2, COL3A1, COL4A1, and RAC2 were significantly correlated with CKD. The lncRNAs of NOP14-AS1 and HCP5 were potential prognostic biomarkers for predicting the risk of CKD.
Subject(s)
Humans , RNA, Messenger/genetics , Genetic Markers/genetics , Renal Insufficiency, Chronic/genetics , RNA, Long Noncoding/genetics , Prognosis , Case-Control Studies , Mass Screening , Gene Expression Profiling , Renal Insufficiency, Chronic/diagnosisABSTRACT
ABSTRACT There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population. These variants made their way to South America trough intercontinental slave traffic and conferred an evolutionary advantage to the carries by protecting against forms of trypanosomiasis, but at the expense of an increased risk of kidney disease. The effect of the variants does not seem to be related to their serum concentration, but rather to local action on the podocytes. Risk variants are also important in renal transplantation, since grafts from donors with risk variants present worse survival.
RESUMO Existem importantes diferenças na doença renal crônica entre caucasianos e afrodescendentes. Foi amplamente aceito que isso ocorreu devido a fatores socioeconômicos, mas estudos recentes mostraram que as variantes gênicas da apolipoproteína L-1 (APOL1) estão fortemente associadas à glomeruloesclerose segmentar e focal, nefropatia associada ao HIV, nefroesclerose hipertensiva e nefrite lúpica na população afrodescendente. Essas variantes chegaram à América do Sul através do tráfico intercontinental de escravos, e proporcionaram uma vantagem evolutiva aos portadores, protegendo contra formas de tripanossomíase, mas à custa de um maior risco de doença renal. O efeito das variantes não parece estar relacionado à sua concentração sérica, mas sim à sua ação local sobre os podócitos. Variantes de risco também são importantes no transplante renal, já que enxertos de doadores com variantes de risco apresentam pior sobrevida.
Subject(s)
Humans , Renal Insufficiency, Chronic/genetics , Apolipoprotein L1/genetics , Polymorphism, Genetic , Genetic Variation , Black or African American/genetics , Cardiovascular Diseases/etiology , Cardiovascular Diseases/epidemiology , Prevalence , Risk Factors , Podocytes , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/etiology , Renal Insufficiency, Chronic/epidemiology , Apolipoprotein L1/physiologyABSTRACT
ABSTRACT Chronic kidney disease (CKD) is a multifactorial pathophysiologic irreversible process that often leads to a terminal state in which the patient requires renal replacement therapy. Most cases of CKD are due to chronic-degenerative diseases and endothelial dysfunction is one of the factors that contribute to its pathophysiology. One of the most important mechanisms for proper functioning of the endothelium is the regulation of the synthesis of nitric oxide. This compound is synthesized by the enzyme nitric oxide synthase, which has 3 isoforms. Polymorphisms in the NOS3 gene have been implicated as factors that alter the homeostasis of this mechanism. The Glu298Asp polymorphisms 4 b/a and -786T>C of the NOS3 gene have been associated with a more rapid deterioration of kidney function in patients with CKD. These polymorphisms have been evaluated in patients with CKD of determined and undetermined etiology and related to a more rapid deterioration of kidney function.
RESUMO A insuficiência renal crônica (IRA) é um processo fisiopatológico multifatorial e irreversível que frequentemente conduz a um estado terminal no qual o paciente passa a necessitar de tratamento por transplante renal. A maioria dos casos de IRA são devidos a doenças crônicas degenerativas; a disfunção endotelial é um dos fatores contribuintes na fisiopatologia. Um dos mecanismos mais importantes para o funcionamento adequado do endotélio é a regulação da síntese de óxido nítrico. Este composto é sintetizado por meio da enzima sintase do óxido nítrico, que tem três isoformas. Os polimorfismos no gene NOS3 tem sido implicados como fatores que alteram a homeostase desse mecanismo. Os polimorfismos Glu298Asp 4 b/a e -786T>C do gene NOS3 têm sido associados a uma deterioração mais rápida da função renal nos pacientes com IRA. Estes polimorfismos têm sido avaliados em pacientes com IRA de causas determinadas ou não-determinadas e relacionados a uma perda mais rápida da função renal.
Subject(s)
Humans , Polymorphism, Genetic , Renal Insufficiency, Chronic/genetics , Nitric Oxide Synthase Type III/geneticsABSTRACT
Objective: Despite the huge efforts, chronic kidney disease [CKD] remains as an unsolved problem in medicine. Many studies have shown a central role for transforming growth factor beta-1 [TGF beta-1] and its downstream signaling cascades in the pathogenesis of CKD. In this study, we have reanalyzed a microarray dataset to recognize critical signaling pathways controlled by TGF beta-1
Materials and Methods: This study is a bioinformatics reanalysis for a microarray data. The GSE23338 dataset was downloaded from the gene expression omnibus [GEO] database which assesses the mRNA expression profile of TGF beta-1 treated human kidney cells after 24 and 48 hours incubation. The protein interaction networks for differentially expressed [DE] genes in both time points were constructed and enriched. In addition, by network topology analysis, genes with high centrality were identified and then pathway enrichment analysis was performed with either the total network genes or with the central nodes
Results: We found 110 and 170 genes differentially expressed in the time points 24 and 48 hours, respectively. As the genes in each time point had few interactions, the networks were enriched by adding previously known genes interacting with the differentially expressed ones. In terms of degree, betweenness, and closeness centrality parameters 62 and 60 nodes were considered to be central in the enriched networks of 24 hours and 48 hours treatment, respectively. Pathway enrichment analysis with the central nodes was more informative than those with all network nodes or even initial DE genes, revealing key signaling pathways
Conclusion: We introduced a method for the analysis of microarray data that integrates the expression pattern of genes with their topological properties in protein interaction networks. This holistic novel approach allows extracting knowledge from raw bulk omics data
Subject(s)
Microarray Analysis , Transforming Growth Factor beta1 , Renal Insufficiency, Chronic/genetics , Systems BiologySubject(s)
Animals , Dogs , Gene Expression , Leishmania infantum , Renal Insufficiency, Chronic/veterinary , Leishmaniasis, Visceral/veterinary , Membrane Proteins/genetics , Polymerase Chain Reaction/veterinary , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/parasitology , Leishmaniasis, Visceral/genetics , Membrane Proteins/analysisABSTRACT
Introducción: el trasplante es la terapia que permite la mayor sobrevida a los pacientes con insuficiencia renal crónica. Para prevenir el rechazo del órgano, en primer lugar es necesario un estudio de la compatibilidad de los antígenos leucocitarios humanos (HLA) del paciente y de los posibles donantes. En Cuba solo se había realizado la tipificación HLA por métodos serológicos, pero en la actualidad se emplean técnicas moleculares. Objetivo: caracterizar el polimorfismo de los alelos HLA A, B, DR y DQ por métodos moleculares en pacientes cubanos en espera de trasplante renal. Métodos: se estudiaron 410 pacientes con insuficiencia renal crónica de las regiones occidental y central del país a los que se les realizó tipificación molecular de los loci mencionados. Los resultados se expresaron según la nueva nomenclatura y fueron registrados en una base de datos confeccionada al efecto. Se compararon las frecuencias alélicas de la población blanca y no blanca y se determinó el porcentaje de frecuencia de los haplotipos para los alelos clase I y II. Resultados: los alelos A*11, A*30, A*74, B*42, B*51 y B*53 fueron más frecuentes en la población blanca mientras que los alelos B*58 y DRB1* 15 predominaron en los no blancos. Las frecuencias haplotípicas más encontradas en la clase I en la población blanca fueron A*02 B*51, A*02 B*44, A*02 B*35; y en la no blanca, A*01B*08, A*02B*51, A*02B*44. Para los alelos de la clase II, en la población blanca fueron DQB1*03, DRB1*04, DQB1*06, DRB1*13, DRB1*05, DRB1*01; y en los no blancos, DQB1*03, DRB1*04, DQB1*06, DRB1*13, DQB1*05, DRB1*01. Conclusiones: la caracterización de los pacientes con insuficiencia renal crónica con respecto a su tipificación HLA permitirá trazar estrategias futuras relacionadas con la donación y el trasplante en todo el país(AU)
Introduction: transplantation is the therapy allowing the highest possible survival in patients with chronic kidney insufficiency. To prevent rejection of the organ, first of all it is necessary to make a compatibility test of human leukocyte antigens (HLA) from the patient and the possible donors. In Cuba, only serological HLA typing had been made but at present, molecular techniques are being applied. Aim: characterization of polimorfirsm of alleles HLA A, B, DR y DQ by molecular techniques in Cuban patients awaiting renal transplantation. Methods: four hundred and ten patients with chronic kidney insufficiency from Western and Central Cuba were studied by molecular typing of the above mentioned loci. Results were expressed by the new nomenclature and were registered In a data base prepared for that purpose. Allele frequencies of white and no white population were compared and percentage of haplotype frequencies for alleles class I and II were determined. Results: alleles A*11, A*30, A*74, B*42, B*51and B*53 were more frequent in white population while B*58 y DRB1*, 15 were mostly found in no whites. Haplotypic frequencies most found in class I in white population were A*02 B*51, A*02 B*44, A*02 B*35; and in no whites, A*01B*08, A*02B*51, A*02B*44. For class II alleles, DQB1*03, DRB1*04, DQB1*06, DRB1*13, DRB1*05, DRB1*01 were the most found in white population; and in no whites, DQB1*03, DRB1*04, DQB1*06, DRB1*13, DQB1*05, DRB1*01. Conclusions: characterization of patients with chronic kidney insufficiency in respect to HLA typing will allow future strategies related to kidney donation and transplantation in the whole country(AU)
Subject(s)
Humans , Male , Female , HLA Antigens/immunology , Renal Insufficiency, Chronic/genetics , Cuba , Histocompatibility Testing/methods , Kidney Transplantation/methodsABSTRACT
Objective To establish whether the mutation in the Immp2L gene induces renal fibrosis and whether aging exacerbates renal morphology in mice. Methods Female mutant mice with mutation in the inner mitochondrial membrane peptidase 2-like protein at 3 and 18 months of age were used. Renal fibrosis was analyzed using classic fibrosis score, Masson’s trichrome staining, and analysis of profibrotic markers using real time polymerase chain reaction (superoxide dismutase 1, metalloproteinase-9, erythropoietin, transforming growth factor beta), and immunostaining (fibroblasts and Type IV collagen). Oxidative stress markers were determined by immunohistochemistry. The number of renal apoptotic cells was determined. Renal function was estimated by serum creatinine. Results Young mutant mice had significantly more glomerulosclerosis than age-matched mice (p=0.034). Mutant mice had more tubular casts (p=0.025), collagen deposition (p=0.019), and collagen type IV expression (p<0.001). Superoxide dismutase 1 expression was significantly higher in young mutants (p=0.038). Old mutants exhibited significantly higher expression of the fibroblast marker and macrophage marker (p=0.007 and p=0.012, respectively). The real time polymerase chain reaction of metalloproteinase-9 and erythropoietin were enhanced 2.5- and 6-fold, respectively, in old mutants. Serum creatinine was significantly higher in old mutants (p<0.001). Conclusion This mutation altered renal architecture by increasing the deposition of extracellular matrix, oxidative stress, and inflammation, suggesting a protective role of Immp2L against renal fibrosis. .
Objetivo Estabelecer se a mutação no gene Immp2L induz à fibrose renal e se o envelhecimento exacerba a morfologia renal em camundongos. Métodos Foram usadas fêmeas de camundongos mutantes para proteína semelhante à peptidase 2 da camada interna da mitocôndria, com 3 e 18 meses de idade. Para analisar a fibrose renal, foram usados o escore clássico de fibrose, a coloração com tricrômio de Masson, e a análise de marcadores profibróticos, por meio da reação em cadeia de polimerase em tempo real (superóxido dismutase 1, metalonoproteinase-9, eritropoietina e fator transformador de crescimento beta), e a imunocoloração (fibroblastos e colágeno IV). Marcadores de estresse oxidativo foram determinados por imuno-histoquímica. O número de células apoptóticas renais foi analisado. A função renal foi estimada por creatinina sérica. Resultados Camundongos mutantes jovens apresentaram glomeruloesclerose em quantidade significativamente maior que animais da mesma idade (p=0,034). Os mutantes mostraram maior formação de cilindros tubulares (p=0,025), deposição de colágeno (p=0,019) e maior expressão de colágeno do tipo IV (p<0,001). A expressão de superóxido dismutase 1 foi maior em mutantes jovens (p=0,038). Mutantes idosas exibiram maior expressão dos marcadores de fibroblastos e macrófagos (p=0,007 e p=0,012, respectivamente). As reações da cadeia de polimerase em tempo real da metalanoproteinase-9 e da eritropoietina estavam aumentadas em 2,5 e 6 vezes, respectivamente, em mutantes idosas. A creatinina sérica foi significantemente maior em animais idosos mutantes (p<0,001). Conclusão Essa mutação alterou a arquitetura renal pelo aumento da deposição de matriz extracelular, estresse oxidativo e inflamação, sugerindo papel de proteção de Immp2L contra a fibrose renal. .
Subject(s)
Animals , Female , Mice , Disease Models, Animal , Endopeptidases/genetics , Endopeptidases/metabolism , Kidney/metabolism , Kidney/pathology , Mutation/physiology , Superoxides/metabolism , Apoptosis/genetics , Apoptosis/physiology , Collagen/analysis , Creatinine/blood , Erythropoietin/analysis , Fibrosis/genetics , Fibrosis/metabolism , Matrix Metalloproteinase 9/analysis , Oxidative Stress/genetics , Oxidative Stress/physiology , Real-Time Polymerase Chain Reaction , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/metabolism , Superoxide Dismutase/analysis , Superoxides/analysis , Transforming Growth Factor beta/analysisABSTRACT
INTRODUÇÃO: O histórico familiar positivo para a doença renal crônica (HF+) é um fator de risco para o surgimento e desenvolvimento dessa doença. Desta forma, é importante avaliar traços que possam estar correlacionados à predisposição familiar para a doença renal crônica. OBJETIVO: Avaliar a modulação autonômica, pela variabilidade da frequência cardíaca, de indivíduos com HF+. MÉTODOS: Foram avaliados nove indivíduos saudáveis com HF+ e 22 indivíduos saudáveis com histórico familiar negativo para doença renal crônica (Grupo HF-), pareados por idade (27 ± 6 vs. 26 ± 4 anos; p = 0,39, respectivamente). A frequência cardíaca foi medida continuamente pelo cardiofrequencímetro Polar S810i® durante 10 minutos de repouso na posição supina. A Variabilidade da Frequência Cardíaca (VFC) foi avaliada pelos índices do domínio do tempo, média dos intervalos RR (MNN), desvio padrão dos intervalos RR (SDNN), raiz média quadrática das diferenças de intervalos RR sucessivos (RMSSD) e percentual de intervalos RR com diferença de duração maior que 50 ms (pNN50), e pelos domínios de baixa frequência (BF), alta frequência (AF) e razão baixa/alta (BF/AF). Os exames laboratoriais foram realizados após jejum de 12 horas. Os resultados são expressos como média ± desvio padrão, adotando como significativo p < 0,05. RESULTADOS: Os grupos HF+ e HFforam semelhantes em relação à estimativa da taxa de filtração glomerular (p = 0,49) e frequência cardíaca (p = 0,68). Os grupos HF+ e HF- não apresentaram diferenças significativas em relação aos índices da variabilidade da frequência cardíaca MNN; SDNN, RMSSD, pNN50, Potência total; BF; AF u.n e razão BF/AF. CONCLUSÃO: A modulação autonômica cardíaca está preservada em indivíduos saudáveis com HF+.
INTRODUCTION: The positive family history of chronic kidney disease (FH+) is a risk factor for the appearance and development of this disease. Thus, it is important to assess traits that may be related to familial predisposition to chronic kidney disease. OBJECTIVE: To evaluate the autonomic modulation by heart rate variability in individuals with FH+. METHODS: We studied 9 health subjects with FH+ and 22 health subjects with negative family history for chronic kidney disease (FH-) matched for age (27 ± 6 vs. 26 ± 4 anos; p = 0.39, respectively). Heart rate was measured continuously by the Polar S810i® for 10 minutes of rest in the supine position. The heart rate variability was evaluated by the time domain, mean of NN intervals (MNN), standard deviation of the NN intervals (SDNN), root mean squared differences of successive NN intervals (RMSSD) and percentage of NN intervals with a difference of duration greater than 50 ms (pNN50) and the fields of low frequency (LF), high frequency (HF) and ratio low/ high (LF/HF). Laboratory biochemical tests were performed after fasting for 12 hours. Results are expressed as mean ± standard deviation, adopting as significant p < 0.05. RESULTS: The groups FH+ and FH-were similar in serum creatinine (p = 0.98), estimated glomerular filtration rate (p = 0.49) and heart rate (p = 0.68). The groups FH+ and FH- showed no significant differences in relation to indices of heart rate variability MNN; SDNN; RMSSD; pNN50; Total power; LF; HF and LF/HF ration, respectively. CONCLUSION: These findings suggest that the cardiac autonomic modulation is preserved in health subjects with HF+.
Subject(s)
Adult , Female , Humans , Male , Young Adult , Autonomic Nervous System/physiology , Heart Rate/physiology , Renal Insufficiency, Chronic/genetics , Risk FactorsABSTRACT
En publicaciones previas se muestra que familiares con vínculo primario de pacientes con enfermedad renal crónica tienen mayor riesgo de desarrollar la enfermedad que la población general. Objetivo: conocer la frecuencia relativa de marcadores de enfermedad renal crónica y factores de riesgo cardiovascular entre familiares con vínculo primario de pacientes en diálisis. Material y métodos: se estudiaron 810 voluntarios, 668 mayores de 18 años. Se les realizó una encuesta sobre antecedentes de enfermedad renal y cardiovascular. Se midieron presión arterial y datos antropométricos, y se tomaron muestras para análisis de orina y sangre. Los parámetros valorados en la población adulta fueron: hábito de fumar, presencia de hipertensión arterial (HTA), obesidad, diabetes, hipercolesterolemia, creatininemia y clearance de creatinina estimado por MDRD, proteinuria y microalbuminuria por tira reactiva con lectura digital. En población pediátrica se consideraron los percentilos para peso y presión arterial. Se clasificó a la población por estadios de enfermedad renal crónica según recomendación de la National Kidney Foundation. Resultados: Frecuencias relativas de ERC= 29.6%; proteinuria = 13.9% y microalbuminuria= 8.7%. Las frecuencias relativas, ajustadas por sexo y edad, fueron: de HTA 41.8%, sobrepeso/obesidad 62.1%, e hipercolesterolemia 42.9%, y de hiperglucemia 5.2%. El 34.8% de los encuestados eran fumadores. En conclusión: En población adulta la prevalencia de sobrepeso/obesidad, hipertensión arterial e hipercolesterolemia entre familiares con vínculo primario de pacientes en TSR fue más elevada que las comunicadas en estudios poblaciones nacionales. La prevalencia de enfermedad renal crónica también fue elevada, estimándose en tres veces superior a la de la población general. Estos resultados apoyan el hecho que los familiares con vínculo primario de pacientes en diálisis constituyen una población de alto riesgo de enfermedad renal crónica.
Background: It has been established that first-degree relatives of patients with chronic kidney disease (CKD) have a higher CKD risk than the overall population. This paper deals with the relative frequency of CKD markers and cardiovascular (CV) risk factors within first-degree relatives of ESRD patients in Argentina. Methods: 810 family members volunteered to participate; of them 668 over 18 ys. old. Trained nurses interviewed them and completed a questionnaire dealing with family history of renal and cardiovascular disease. Blood pressure, urine and blood analysis and anthropometric data were collected. Selected parameters were: smoking habit, presence of high blood pressure, diabetes, hypercholesterolemia, high plasma creatinine and creatinine clearance estimated by MDRD formula, proteinuria and microalbuminuria. In pediatric population, weight and blood pressure parameters were evaluated as percentiles. CKD were classified in stage (National Kidney Foundation). Results: The relative frequencies were: CKD: 29.6%; proteinuria: 13.9%; microalbuminuria: 8.7%. The prevalence values found for main CV risks factors, adjusted by sex and age, were: high blood pressure= 41.8%; overweight/obesity by BMI= 62.1%, hypercholesterolemia= 42.9% and hyperglycemia= 5.2%. Smoking habit was present in 34.8%. In conclusion: Prevalence of overweight/obesity, hypertension and hypercholesterolemia in first-degree relatives of ESRD patients is higher than previously communicated in studies of national reference populations. Prevalence of CKD is high, estimated as three-fold higher than for a general population as reported in poblational studies. These results support the fact that first-degree relatives of ESRD patients, as has been established elsewhere, constitute a population at high risk for developing ESRD.
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Adult , Family Health , Nuclear Family , Renal Dialysis , Renal Insufficiency, Chronic/epidemiology , Argentina/epidemiology , Biomarkers/blood , Cross-Sectional Studies , Creatine/blood , Glomerular Filtration Rate , Hypertension/epidemiology , Mass Screening , Obesity/epidemiology , Proteinuria/urine , Risk Factors , Renal Insufficiency, Chronic/genetics , Smoking/adverse effectsABSTRACT
O polimorfismo (I/D) inserçäo/deleçäo do gene da enzima de conversäo da angiotensina (ECA) se correlaciona com a concentraçäo celular e circulante da ECA. Indivíduos com genótipo D/D têm concentraçäo circulante de ECA mais elevada de que aqueles com genótipo I/I. O genótipo I/D tem concentraçäo intermediária. O genótipo D/D tem sido associado com o desenvolvimento e/ou progressäo da doença renal e como fator de risco para doença cardiovascular, podendo ser um marcador de hipertrofia ventricular esquerda (HVE). Este trabalho avalia o polimorfismo do gene da ECA por técnica de PCR em 23 pacientes hemodialisados com IRC terminal de diversas etiologias e também sua associaçäo com HVE. Foram estudados 12 pacientes do sexo masculino e 11 do sexo feminino, com idade de 33,9 ñ 16,0 anos. A distribuiçäo dos genótipos da ECA foi comparada com 20 indivíduos saudáveis, sendo 11 do sexo masculino e 9 do sexo feminino, com idade de 31,4 ñ 8,0 anos. A distribuiçäo do genótipo da ECA nos pacientes renais crônicos foi de 60,9 por cento I/D, 34,8 por cento D/D e 4,3 por cento I/I. No grupo-controle foi de 6,0 por cento I/D, 25,0 por cento D/D e 15,0 por cento I/I. Näo houve diferença estatisticamente significante na distribuiçäo do genótipo entre os grupos (P>0,05). Todos os pacientes apresentavam HVE e näo houve diferença estatística significante no índice de massa do ventrículo esquerdo entre os pacientes com genótipo I/D ou D/D. Concluímos que na populaçäo estudada de pacientes com IRC terminal näo houve associaçäo entre o genótipo D/D da ECA e a presença de nefropatia crônica ou hipertrofia ventricular esquerda.